Cargando…
Inadvertent treatment of hypoadrenalism with prednisolone in pemphigus: A case report
Pituitary and adrenal insufficiency must not be overlooked when weaning patients down from high‐dose steroids. Prednisolone can be used as glucocorticoid replacement therapy, with most patients needing 3‐4 mg once daily.
Autores principales: | Choudhury, Sirazum, Machenahalli, Pratibha, Tan, Tricia, Meeran, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510007/ https://www.ncbi.nlm.nih.gov/pubmed/31110731 http://dx.doi.org/10.1002/ccr3.2132 |
Ejemplares similares
-
The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
por: Choudhury, Sirazum, et al.
Publicado: (2021) -
Optimising prednisolone or prednisone replacement in adrenal insufficiency
por: Sharma, Angelica, et al.
Publicado: (2023) -
Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
por: Smith, David J F, et al.
Publicado: (2017) -
Avelumab inducing hypothyroidism and hypoadrenalism: A case report and review of literature
por: Aziz, Kashif, et al.
Publicado: (2018) -
Hypoadrenalism as the Single Presentation of Autoimmune Polyglandular Syndrome Type 1
por: Nasser, Nadim H, et al.
Publicado: (2021)